Ultragenyx Pharmaceutical Inc. (RARE)
NASDAQ · Healthcare
Ultragenyx Pharmaceutical Inc. Revenue 2016–2025
Ultragenyx Pharmaceutical Inc. annual/quarterly revenue history and growth rate from 2016 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Ultragenyx Pharmaceutical Inc. revenue for the quarter ending March 31, 2026 was 136.0 M, a 2.16% decrease year-over-year.
- Ultragenyx Pharmaceutical Inc. revenue for the twelve months ending March 31, 2026 was 601.4 M, a 21.89% increase year-over-year.
- Ultragenyx Pharmaceutical Inc. annual revenue for 2025 was 673.0 M, a 20.18% increase from 2024.
- Ultragenyx Pharmaceutical Inc. annual revenue for 2024 was 560.0 M, a 29.03% increase from 2023.
- Ultragenyx Pharmaceutical Inc. annual revenue for 2023 was 434.0 M, a 19.45% increase from 2022.
- Ultragenyx Pharmaceutical Inc. annual revenue for 2022 was 363.3 M.
Revenue
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Ultragenyx Pharmaceutical Inc. Earnings — FAQ
Ultragenyx Pharmaceutical Inc. (RARE) earnings over the last 10 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see RARE's earnings history?
The chart and table above show Ultragenyx Pharmaceutical Inc.'s earnings by year and by quarter, including the growth rate.